<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01009658</url>
  </required_header>
  <id_info>
    <org_study_id>GU-696</org_study_id>
    <secondary_id>GU-CT 696</secondary_id>
    <nct_id>NCT01009658</nct_id>
  </id_info>
  <brief_title>MSG and Gastrointestinal Motility</brief_title>
  <official_title>Effect of Monosodium Glutamate on Upper Gastrointestinal Tract Motility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gunma University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gunma University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to clarify the physiological function of sodium glutamate by
      measuring its effect on upper GI motility ( gastric emptying).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Amino acids such as monosodium glutamate are known to stimulate both endocrine and exocrine
      secretion. In addition, there is a report that oral intake of glutamate evokes the activation
      of vagal afferent nerves in the rat. Thus, such amino acids are thought to be influential in
      the process of digestion and absorption.

      . To investigate the effect of monosodium glutamate on gastrointestinal motility, we planned
      a single-blind randomized study. The participants will take either monosodium glutamate or
      sodium chloride before the first examination of upper GI motility and the other agent before
      the second examination. The order of intake will be randomized by the envelope method.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastric emptying</measure>
    <time_frame>0-5 hours</time_frame>
    <description>half emptying time</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gastroesophageal Reflux</condition>
  <arm_group>
    <arm_group_label>MSG first</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>NaCl first</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Monosodium glutamate</intervention_name>
    <description>Oral intake of 2.0 g of monosodium glutamate on the examination day and 0.6 g of sodium chloride on the other examination day.</description>
    <arm_group_label>MSG first</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sodium chloride</intervention_name>
    <description>Oral intake of 0.6 g of sodium chloride on the examination day and 2.0 g of monosodium glutamate on the other examination day.</description>
    <arm_group_label>NaCl first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects

          -  Must not have digestive symptoms

          -  Must not eat within six hours of study participation

        Exclusion Criteria:

          -  Regular medications for the gastrointestinal tract

          -  Previous Helicobacter pylori infection

          -  Previous abdominal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gunma university hospital</name>
      <address>
        <city>Maebashi</city>
        <state>Gunma</state>
        <zip>3718511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2009</study_first_submitted>
  <study_first_submitted_qc>November 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2009</study_first_posted>
  <last_update_submitted>March 25, 2015</last_update_submitted>
  <last_update_submitted_qc>March 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gunma University</investigator_affiliation>
    <investigator_full_name>Hiroko Hosaka</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Gastrointestinal motility</keyword>
  <keyword>Gastroesophageal reflux</keyword>
  <keyword>Gastric emptying</keyword>
  <keyword>Sodium glutamate</keyword>
  <keyword>Lower esophageal sphincter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

